Close

SPT Labtech Announces a Co-Marketing Initiative with Thermo Fisher Scientific to Help Reduce the Cost of NGS Library Prep

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

O-1A Visa Evidence for Pharma and Biotech Professionals: What Actually Proves Extraordinary Ability

Important pharmaceutical work is not always publicly visible. A medicinal...

CDSCO to Introduce Integrated Drug Regulatory Platform in 18 Months

The Central Drugs Standard Control Organisation (CDSCO) has announced...

Resilience and Eli Lilly Expand Strategic Partnership with $750 Million Ohio Manufacturing Investment

Resilience has announced an expansion of its strategic partnership...
- Advertisement -

The cost of library preparation is one of the biggest obstacles to large next-generation sequencing (NGS) studies, slowing down the pace of insights from infectious disease surveillance, cancer research and beyond. At the Festival of Genomics, SPT Labtech announced an initiative with Thermo Fisher Scientific to co-market solutions that will enable variant detection at a fraction of the cost.

Sensitive variant detection can now be achieved at one-tenth of the library prep cost through miniaturization with the SPT Labtech mosquito HV genomics and SPT Labtech dragonfly discovery systems.

By positioning Thermo Fisherโ€™s NGS library preparation kits with the SPT Labtech mosquito HV genomics and SPT Labtech dragonfly discovery systems, reagent volumes requirements are reduced which lower cost and increase the number of replicates for a library preparation.

The initiative will initially support Invitrogen Collibri DNA Library Prep Kits for Illumina Systems and Collibri Library Quantification Kits for use in infectious disease studies, including SARS-CoV-2 research, copy number variation within cancer research, and other variant detection applications.

“Driving down the cost of NGS library construction without sacrificing quality of results represents a big step toward democratizing science,” said Joby Jenkins, director of product strategy for SPT Labtech. “NGS technology evolves quickly and it can be time consuming for individual labs to automate the newest library prep kits. Our goal is to automate and miniaturize processes for NGS so scientists can expand the scope of their research programs and, ultimately, generate insights into human health.”

The Collibri DNA Library Prep Kits for Illumina Systems enable sensitive and reproducible variant detection from small amounts of challenging samples. The mosquito HV genomics and dragonfly discovery systems will allow for more streamlined processing of samples at a reduced cost for applications such as disease research.

About SPT Labtech
SPT Labtech makes products that transform the way scientists work. For nearly two decades, our expert scientists, engineers and business innovators have created innovative solutions for liquid handling, sample preparation and management that help accelerate research and make a real difference to human health. We work collaboratively with our customers, building trusted relationships that enable us to deliver exceptional, personalized experiences designed for real-world challenges in the lab.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Latest stories

Related stories

O-1A Visa Evidence for Pharma and Biotech Professionals: What Actually Proves Extraordinary Ability

Important pharmaceutical work is not always publicly visible. A medicinal...

CDSCO to Introduce Integrated Drug Regulatory Platform in 18 Months

The Central Drugs Standard Control Organisation (CDSCO) has announced...

Resilience and Eli Lilly Expand Strategic Partnership with $750 Million Ohio Manufacturing Investment

Resilience has announced an expansion of its strategic partnership...

WHO Introduces Global Regulatory Framework for Decarbonizing Pharmaceuticals

The World Health Organization (WHO) has officially launched the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป